Literature DB >> 30405215

Human disease mutations highlight the inhibitory function of TIM-3.

Karen O Dixon1, Madhumita Das1, Vijay K Kuchroo2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30405215      PMCID： PMC6452640          DOI： 10.1038/s41588-018-0289-3

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  1 in total

1.  Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.

Authors:  Tenzin Gayden; Fernando E Sepulveda; Dong-Anh Khuong-Quang; Jonathan Pratt; Elvis T Valera; Alexandrine Garrigue; Susan Kelso; Frank Sicheri; Leonie G Mikael; Nancy Hamel; Andrea Bajic; Rola Dali; Shriya Deshmukh; Dzana Dervovic; Daniel Schramek; Frédéric Guerin; Mikko Taipale; Hamid Nikbakht; Jacek Majewski; Despina Moshous; Janie Charlebois; Sharon Abish; Christine Bole-Feysot; Patrick Nitschke; Brigitte Bader-Meunier; David Mitchell; Catherine Thieblemont; Maxime Battistella; Simon Gravel; Van-Hung Nguyen; Rachel Conyers; Jean-Sebastien Diana; Chris McCormack; H Miles Prince; Marianne Besnard; Stephane Blanche; Paul G Ekert; Sylvie Fraitag; William D Foulkes; Alain Fischer; Bénédicte Neven; David Michonneau; Geneviève de Saint Basile; Nada Jabado
Journal:  Nat Genet       Date:  2018-10-29       Impact factor: 38.330
  1 in total
  5 in total

Review 1.  Targeting novel inhibitory receptors in cancer immunotherapy.

Authors:  Quan-Quan Ding; Joe-Marc Chauvin; Hassane M Zarour
Journal:  Semin Immunol       Date:  2020-12-04       Impact factor: 11.130

2.  Single-Cell RNA-seq Reveals Characteristics of Malignant Cells and Immune Microenvironment in Subcutaneous Panniculitis-Like T-Cell Lymphoma.

Authors:  Zifeng Li; Hongsheng Wang; Rui Dong; Jie Man; Li Sun; Xiaowen Qian; Xiaohua Zhu; Ping Cao; Yi Yu; Jun Le; Yang Fu; Ping Wang; Wenjin Jiang; Chen Shen; Yangyang Ma; Lian Chen; Yaochen Xu; Jiantao Shi; Hui Zhang; Maoxiang Qian; Xiaowen Zhai
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

3.  In-Depth Analysis of the Plasma Proteome in ME/CFS Exposes Disrupted Ephrin-Eph and Immune System Signaling.

Authors:  Arnaud Germain; Susan M Levine; Maureen R Hanson
Journal:  Proteomes       Date:  2021-01-29

Review 4.  Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases.

Authors:  Xin Cai; Huajie Zhan; Yuguang Ye; Jinjin Yang; Minghui Zhang; Jing Li; Yuan Zhuang
Journal:  Front Genet       Date:  2021-11-30       Impact factor: 4.599

5.  Characterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptor.

Authors:  Stephanie Schwartz; Nidhi Patel; Tyler Longmire; Pushpa Jayaraman; Xiaomo Jiang; Hongbo Lu; Lisa Baker; Janelle Velez; Radha Ramesh; Anne-Sophie Wavreille; Melanie Verneret; Hong Fan; Tiancen Hu; Fangmin Xu; John Taraszka; Marc Pelletier; Joy Miyashiro; Mikael Rinne; Glenn Dranoff; Catherine Sabatos-Peyton; Viviana Cremasco
Journal:  Immunother Adv       Date:  2022-08-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.